|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 |
| (11) | Number of the document | 2841456 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13720714.8 |
| Date of filing the European patent application | 2013-04-25 | |
| (97) | Date of publication of the European application | 2015-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/038135 |
| Date | 2013-04-25 |
| (87) | Number | WO 2013/163377 |
| Date | 2013-10-31 |
| (30) | Number | Date | Country code |
| 201261639637 P | 2012-04-27 | US |
| (72) |
ANDERSEN, Mette, Dahl, DK
DANTZLER, Jeff, US
ARMITAGE, Richard, J., US
CLARK, Rutilio, US
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, US |
| (54) | HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS |
| HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS |